Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/7/2026

1. TTD
2. NET
3. ABNB
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. U
10. SPY

Go back to Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2

Geron Corporation (GERN) halted; discontinuing phase 2 study of imetlstat

September 10, 2012 7:31 AM EDT

Geron Corporation (NASDAQ: GERN) halted; discontinuing phase 2 study of imetlstat... More